En date du mois d’octobre 2016, la valeur d’exportation totale de RemsimaMC avait atteint 1 billion de dollars (Korea International Trade Association).
32pays
Nombre de sociétés filiales à l’étranger
Nombre de pays où sont situées les sociétés filiales à l’étranger de Celltrion Healthcare (2019).
38partenaires
Nombre de partenaires mondiaux
Partenaires mondiaux responsables de la distribution des médicaments biologiques avec Celltrion Healthcare (2019).
52%
La part de marché de RemsimaMC, qui est plus élevée que son médicament d’origine
RemsimaMC est le premier anticorps monoclonal biosimilaire dont la part de marché est plus élevée que celle de son médicament d’origine en Europe (2017).
110pays
Marché de la vente
Le nombre de pays où les biosimilaires principaux de Celltrion Healthcare sont en vente (et où ils sont officiellement approuvés [en 2019]).
1billion (KRW)
La valeur annuelle des prescriptions de RemsimaMC dans le monde.
Pour la première fois en tant que médicament coréen, la valeur annuelle des prescriptions de RemsimaMC autour du monde a atteint 1 billion de dollars KRW (2018).
The Celltrion Healthcare Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions.
If you are a resident of a country other than those to which the site is directed, please contact your local Celltrion Healthcare affiliate to obtain the appropriate product information for your country of residence.
The Celltrion Healthcare site that you have requested may be in a language that differs from your country of origin.
The Celltrion Healthcare site that you have requested may not be optimised for your screen size.
The Celltrion Healthcare Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions.
If you are a resident of a country other than those to which the site is directed, please contact your local Celltrion Healthcare affiliate to obtain the appropriate product information for your country of residence.
The Celltrion Healthcare site that you have requested may be in a language that differs from your country of origin.
The Celltrion Healthcare site that you have requested may not be optimised for your screen size.
Cookie technology helps us bring you the best possible experience when you visit this website. If you continue without changing your settings, you are agreeing to the cookies on this website. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.